PAR 4.65% 20.5¢ paradigm biopharmaceuticals limited..

By the way, when did we reduce to a 300 patientP3 study. Thought...

  1. 1,661 Posts.
    lightbulb Created with Sketch. 177
    By the way, when did we reduce to a 300 patient
    P3 study. Thought we were still circa 400. Hope
    there is already tacit approval from FDA, or there
    maybe some unpleasant surprises.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.